TRICARE covers certain COVID clinical trials

December 11, 2020

Effective October 30, 2020, clinical trials sponsored by or in collaboration with the National Institute of Allergy and Infectious Disease (NIAID) will be covered for the treatment and prevention of COVID-19. This change is effective for the duration of the president’s national emergency regarding COVID-19; however, if a beneficiary has been enrolled in a NIAID-sponsored trial during the national emergency, they will continue to have their cost shared for the duration of the trial, even if the public health emergency has ended.

Please use Special Processing Code (SPC) “CO – NIAID COVID-19 Clinical Trials” to identify these TRICARE Encounter Data (TED) records. This new code should be used in conjunction with “CC” whenever COVID-19 testing is included as part of a NIAID clinical trial. SPC “CO” should not be coded on the TED records with SPC “CV.”